A us distributor contacted zoll to report that a (b)(6) patient passed away in the hospital with a nurse present on (b)(6) 2020 while wearing the lifevest.Clinical review of the patient's download data revealed that prior to passing, the patient experienced two inappropriate treatments, and one appropriate treatment from the lifevest.The patient's nurse reportedly witnessed the first treatment and reported that there were no alarms.The device is currently being evaluated and alarm functionality will be confirmed.Per clinical review, at 23:29:39 on (b)(6) 2020, the patient received the first inappropriate treatment from the lifevest.The patient's rhythm at the time of the treatment was supraventricular tachycardia (svt) at 130 bpm, and the post-shock rhythm was atrial fibrillation (af) at 70 bpm.Motion artifact was also observed on the ecg following the shock.Approximately 7 hours later, at 06:45:44 on (b)(6) 2020, the patient received the second inappropriate treatment from the lifevest.The patient's rhythm at the time of the treatment was svt at 140 bpm, and the post-shock rhythm was af at 80 bpm transitioning to sinus rhythm at 80 bpm.Oversensing of amplitude during svt contributed to the rapid rate false detections.At 07:51:38 on (b)(6) 2020, the patient received an appropriate treatment from the lifevest.The patient's rhythm at the time of the treatment was ventricular tachycardia (vt) at 220 bpm with motion artifact and the post-shock rhythm was af at 80 bpm with motion artifact transitioning to bradycardia at 20 bpm with heart block (hb) and motion artifact.A non-treatable rhythm was declared by the lifevest at 07:52:21.It was reported by the patient's nurse that the patient passed away from asystole at an unknown time after the treatments on (b)(6) 2020.Asystole is considered a non-shockable, non-life sustaining rhythm.The response buttons were not pressed during the entire event.
|